High tumor necrosis factor-α in levels in cerebrospinal fluid of cobalamin-deficient patients
✍ Scribed by Giuseppe Scalabrino; Marinella Carpo; Fabrizia Bamonti; Simona Pizzinelli; Carla D'Avino; Nereo Bresolin; Giuseppe Meucci; Vittorio Martinelli; Gian Carlo Comi; Maddalena Peracchi
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 117 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We studied 14 patients with neurological manifestations of subacute combined degeneration (SCD) and 40 control patients not cobalamin (Cbl)‐deficient. The cerebrospinal fluid (CSF) markers of Cbl deficiency (Cbl and total homocysteine [tHCYS] levels) and the CSF levels of tumor necrosis factor (TNF)‐α and epidermal growth factor (EGF) were measured. Significantly higher levels of tHCYS and TNF‐α, and significantly lower levels of Cbl and EGF were found in the SCD patients. In human CSF, as in human serum and the rat central nervous system, decreased Cbl concentrations are concomitant with an increase in TNF‐α and a decrease in EGF‐levels. Ann Neurol 2004;56:886–890
An Erratum has been published for this article in Ann Neurol 57: 304, 2005.
📜 SIMILAR VOLUMES
To investigate the prognostic role of tumour ne-It is a major public health problem in several parts of crosis factor (TNF) in Japanese encephalitis virus Southeast Asia including India . (JEV) infection, we measured the immunoreac- The mortality in this acute encephalitic illness has vartive forms
Steady-state sickle cell disease (SCD) patients may have increased plasma levels of acute phase reactants and pro-inflammatory cytokines because of subclinical inflammation. We have estimated TNF-␣ levels in the plasma and in supernatants following peripheral blood mononuclear cell (PBMC) activation